10
Participants
Start Date
July 16, 2025
Primary Completion Date
December 15, 2025
Study Completion Date
December 30, 2025
BKR-017
BKR-017 is an oral tablet formulation designed to target delivery of sodium butyrate to the colon via colon-targeting technology.
RECRUITING
Pennington Biomedical Research Center, Baton Rouge
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
BioKier Inc.
INDUSTRY